H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Census population 749,256. Washington Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Seattle clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Seattle storefront.
Extracellular Matrix (ECM) Therapy in Seattle, WA for clinics & physicians. ECM therapy products provide n… Compliance support & pricing — contact Hawk Medical.
6.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Population 749,256. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JF documentation are ready before the first application of extracellular matrix therapy.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)Washington shares JF with AK, AZ, ID, MT, ND, OR, SD, UT, WY. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the extracellular matrix therapy account.
CDC PLACES (2023, crude prevalence) estimates 6.1% of adults — 5.9 points below the U.S. 12% figure. Obesity is 22.2%; arthritis is 17%. That is place-level BRFSS modeling, not a clinic census and not a Seattle trial.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Bring specialty, monthly joint / regenerative volume, and whether you bill JF FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 6.1% diabetes and 17% arthritis for Seattle — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Seattle, WA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Seattle is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Seattle — 5.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Washington Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, UT, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Seattle. Useful for joint-program math; still needs a diagnosis and privileging.
No Seattle storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.